|
1
|
Chinese Society of Hepatology and Chinese
Society of Infectious Diseases; Chinese Medical Association: The
guideline of prevention and treatment for chronic hepatitis B (2010
version). Zhonghua Gan Zang Bing Za Zhi. 19:13–24. 2011.(In
Chinese). PubMed/NCBI
|
|
2
|
Lu FM and Zhuang H: Management of
hepatitis B in China. Chin Med J (Engl). 122:3–4. 2009.PubMed/NCBI
|
|
3
|
Ren F, Chen Y, Wang Y, Yan Y, Zhao J, Ding
M, Zhang J, Jiang Y, Zhai Y and Duan Z: Comparative serum proteomic
analysis of patients with acute-on-chronic liver failure:
Alpha-1-acid glycoprotein may be a candidate marker for prognosis
of hepatitis B virus infection. J Viral Hepat. 17:816–824. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang L, Rudser KD, Higgins L, Rosen HR,
Zaman A, Corless CL, David L and Gourley GR: Novel biomarker
candidates to predict hepatic fibrosis in hepatitis C identified by
serum proteomics. Dig Dis Sci. 56:3305–3315. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jin GZ, Li Y, Cong WM, Yu H, Dong H, Shu
H, Liu XH, Yan GQ, Zhang L, Zhang Y, et al: iTRAQ-2DLC-ESI-MS/MS
based identification of a new set of immunohistochemical biomarkers
for classification of dysplastic nodules and small hepatocellular
carcinoma. J Proteome Res. 10:3418–3428. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee HJ, Na K, Choi EY, Kim KS, Kim H and
Paik YK: Simple method for quantitative analysis of N-linked
glycoproteins in hepatocellular carcinoma specimens. J Proteome
Res. 9:308–318. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Goh WW, Lee YH, Zubaidah RM, Jin J, Dong
D, Lin Q, Chung MC and Wong L: Network-based pipeline for analyzing
MS data: An application toward liver cancer. J Proteome Res.
10:2261–2272. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu WW, Wang G, Baek SJ and Shen RF:
Comparative study of three proteomic quantitative methods, DIGE,
cICAT and iTRAQ, using 2D gel- or LC-MALDI TOF/TOF. J Proteome Res.
5:651–658. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kolla V, Jenö P, Moes S, Tercanli S,
Lapaire O, Choolani M and Hahn S: Quantitative proteomics analysis
of maternal plasma in Down syndrome pregnancies using isobaric
tagging reagent (iTRAQ). J Biomed Biotechnol.
2010.9520472010.PubMed/NCBI
|
|
10
|
Lok AS and McMahon BJ: Chronic hepatitis
B: update 2009 (AASLD Practice Guidelines). Hepatology. 50:661–662.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sarin SK, Kumar A, Almeida JA, Chawla YK,
Fan ST, Garg H, de Silva HJ, Hamid SS, Jalan R, Komolmit P, et al:
Acute-on-chronic liver failure: consensus recommendations of the
Asian Pacific Association for the study of the liver (APASL).
Hepatol Int. 3:269–282. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vilardell F, Novell A, Martin J, Santacana
M, Velasco A, Díez-Castro MJ, Cuevas D, Panadés MJ, González S,
Llombart A, et al: Importance of assessing CK19 immunostaining in
core biopsies in patients subjected to sentinel node study by OSNA.
Virchows Arch. 460:569–575. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kosacka M and Jankowska R: The prognostic
value of cytokeratin 19 expression in non-small cell lung cancer.
Pneumonol Alergol Pol. 75:317–323. 2007.(In Polish). PubMed/NCBI
|
|
14
|
Fournier T, Medjoubi-N N and Porquet D:
Alpha-1-acid glycoprotein. Biochim Biophys Acta. 1482:157–171.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chirwa N, Govender D, Ndimba B, Lotz Z,
Tyler M, Panieri E, Kahn D and Mall AS: A 40–50 kDa glycoprotein
associated with mucus is identified as α-1-acid glycoprotein in
carcinoma of the stomach. J Cancer. 3:83–92. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Saarnio J, Parkkila S, Parkkila AK,
Haukipuro K, Pastorekova S, Pastorek J, Kairaluoma MI and Karttunen
TJ: Immunohistochemical study of colorectal tumors for expression
of a novel transmembrane carbonic anhydrase, MN/CA IX, with
potential value as a marker of cell proliferation. Am J Pathol.
153:279–285. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yamachika T, Nakanishi H, Yasui K, Ikehara
Y, Niwa T, Wanibuchi H, Tatematsu M and Fukushima S: Establishment
and characterization of a human colonic mucinous carcinoma cell
line with predominant goblet-cell differentiation from liver
metastasis. Pathol Int. 55:550–557. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee WY, Huang SC, Hsu KF, Tzeng CC and
Shen WL: Roles for hypoxia-regulated genes during cervical
carcinogenesis: Somatic evolution during the
hypoxia-glycolysis-acidosis sequence. Gynecol Oncol. 108:377–384.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Elchuri S, Naeemuddin M, Sharpe O,
Robinson WH and Huang TT: Identification of biomarkers associated
with the development of hepatocellular carcinoma in CuZn superoxide
dismutase deficient mice. Proteomics. 7:2121–2129. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang Y, Cai XF, He MR, Zhang J and Huang
AL: Screening of proteins interacting with hepatitis C virus NS3
from T7-phage display library. Zhonghua Gan Zang Bing Za Zhi.
14:561–564. 2006.(In Chinese). PubMed/NCBI
|
|
21
|
Caillot F, Hiron M, Goria O, Gueudin M,
Francois A, Scotte M, Daveau M and Salier JP: Novel serum markers
of fibrosis progression for the follow-up of hepatitis C
virus-infected patients. Am J Pathol. 175:46–53. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ekeowa UI, Marciniak SJ and Lomas DA: α
(1)-antitrypsin deficiency and inflammation. Expert Rev Clin
Immunol. 7:243–252. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen XL, Zhou L, Yang J, Shen FK, Zhao SP
and Wang YL: Hepatocellular carcinoma-associated protein markers
investigated by MALDI-TOF MS. Mol Med Rep. 3:589–596. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tan XF, Wu SS, Li SP, Chen Z and Chen F:
Alpha-1 antitrypsin is a potential biomarker for hepatitis B. Virol
J. 8:2742011. View Article : Google Scholar : PubMed/NCBI
|
